The role of protein p16

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

1. Human β-Defensins in Diagnosis of Head and Neck Cancers.Cells · 2023
   Review
2. Non-negative matrix factorization model-based construction for molecular clustering and prognostic assessment of head and neck squamous carcinoma.Heliyon · 2022
   Article
3. CD8Annals of translational medicine · 2022
   Article
4. Clinical efficacy of an antibody-based detection system for human papilloma virus infection in oral squamous cell carcinoma.Clinical oral investigations · 2021
   Article
5. Clinicopathological Significance of FOXO4 Expression and Correlation with Prx1 in Head and Neck Squamous Cell Carcinoma.Analytical cellular pathology (Amsterdam) · 2021
   Article
6. Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma.Journal of oral and maxillofacial pathology : JOMFP
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 3 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as